Related Experiment Video
Updated: Jun 23, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Insights
A French health insurance survey reveals many children face severe risks from treatments for minor health issues. This highlights potential dangers in pediatric care for common ailments.
Area of Science:
- Pediatric Health
- Pharmacovigilance
- Public Health Policy
Background:
- Mild childhood disorders are frequently treated, often with medications.
- The potential for severe adverse effects from these treatments is not always fully recognized.
- Existing data on treatment risks in pediatric populations for common ailments is limited.
Purpose of the Study:
- To assess the prevalence of severe adverse effects in children undergoing treatment for mild disorders.
- To identify specific treatments associated with higher risk profiles in pediatric patients.
- To inform public health strategies regarding pediatric medication safety.
Main Methods:
- Analysis of data from a French national health insurance branch.
- Retrospective survey of treatment records for common childhood conditions.
- Categorization and severity assessment of reported adverse events.
Main Results:
- A significant number of children experienced severe adverse effects.
- Specific treatments for common, mild conditions were linked to these adverse events.
- The findings indicate a notable underestimation of treatment-related risks in pediatric care.
Conclusions:
- Current treatment practices for mild pediatric disorders may pose substantial risks.
- There is a critical need for improved risk-benefit assessments in pediatric pharmacotherapy.
- Public health interventions are warranted to mitigate severe adverse effects in children.
Abstract:
A survey by a French national health insurance branch shows that a large number of children are exposed to a risk of severe adverse effects due to treatments for mild disorders.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...